Literature DB >> 21676066

Salvage lymphadenectomy for cervical lymph node recurrence after esophagectomy for squamous cell carcinoma of the thoracic esophagus.

M Watanabe1, K Nishida, Y Kimura, M Miyazaki, H Baba.   

Abstract

Prognosis of patients with recurrent esophageal cancer is usually unsatisfactory. We have successfully treated five patients with cervical node recurrence after esophagectomy with multimodal treatment including salvage lymphadenectomy. In order to clarify the efficacy of salvage surgery for cervical node recurrence, we have reviewed the clinical course and prognosis of these patients. From August 2004 to December 2007, 30 patients with 33 recurrent sites were treated in the Department of Surgery, Iizuka Hospital. Among these patients, there were five patients with recurrence limited within the cervical nodes. Salvage cervical lymphadenectomy was performed for all five patients. Curative resection was achieved in four patients and reduction surgery followed by planned chemoradiotherapy was performed in another patient. All stations including the suspicious node were dissected and a partial sternotomy was added for one patient whose recurrent tumor was located in the right recurrent nerve node. There was no mortality and one minor complication (subcutaneous hemorrhage) was observed. Median duration of hospital stay was 7 days. Adjuvant chemotherapy was performed for all patients. Median follow-up period was 54 months and all patients are alive without relapse of the disease. Salvage cervical lymphadenectomy is a safe and effective treatment for patients with cervical node recurrence after esophagectomy.
© 2011 Copyright the Authors. Journal compilation © 2011, Wiley Periodicals, Inc. and the International Society for Diseases of the Esophagus.

Entities:  

Mesh:

Year:  2011        PMID: 21676066     DOI: 10.1111/j.1442-2050.2011.01215.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  11 in total

1.  Outcomes of lymphadenectomy for lymph node recurrence after esophagectomy or definitive chemoradiotherapy for squamous cell carcinoma of the esophagus.

Authors:  Masayuki Watanabe; Shinji Mine; Kazuhiko Yamada; Hironobu Shigaki; Yoshifumi Baba; Naoya Yoshida; Kiyoshi Kajiyama; Noriko Yamamoto; Takeshi Sano; Hideo Baba
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-06-26

2.  Salvage lymphadenectomy for recurrent esophageal cancer after chemoradiotherapy.

Authors:  Masanobu Nakajima; Yasushi Domeki; Hitoshi Satomura; Masakazu Takahashi; Akira Sugawara; Hiroto Muroi; Kinro Sasaki; Satoru Yamaguchi; Tatsuya Miyazaki; Hiroyuki Kuwano; Hiroyuki Kato
Journal:  Int Surg       Date:  2014 Jul-Aug

3.  Salvage lymphadenectomy for isolated cervical lymph node recurrence after curative resection of thoracic esophageal squamous cell carcinoma.

Authors:  Zhen Wang; Shaofeng Lin; Feng Wang; Shuoyan Liu
Journal:  Ann Transl Med       Date:  2019-06

4.  Survival benefit of multimodal local therapy for repeat recurrence of thoracic esophageal squamous cell carcinoma after esophagectomy.

Authors:  Itasu Ninomiya; Koichi Okamoto; Sachio Fushida; Jun Kinoshita; Hiroyuki Takamura; Hidehiro Tajima; Isamu Makino; Tomoharu Miyashita; Tetsuo Ohta
Journal:  Esophagus       Date:  2018-08-28       Impact factor: 4.230

5.  Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2.

Authors:  Yuko Kitagawa; Takashi Uno; Tsuneo Oyama; Ken Kato; Hiroyuki Kato; Hirofumi Kawakubo; Osamu Kawamura; Motoyasu Kusano; Hiroyuki Kuwano; Hiroya Takeuchi; Yasushi Toh; Yuichiro Doki; Yoshio Naomoto; Kenji Nemoto; Eisuke Booka; Hisahiro Matsubara; Tatsuya Miyazaki; Manabu Muto; Akio Yanagisawa; Masahiro Yoshida
Journal:  Esophagus       Date:  2018-08-31       Impact factor: 3.671

6.  The effectiveness and prognostic factors of radioactive iodine-125 seed implantation for the treatment of cervical lymph node recurrence of esophageal squamous cell carcinoma after external beam radiation therapy.

Authors:  Yuwei Zhang; Zezhou Liu; Yansong Liang; Enli Chen; Hongtao Zhang; Zhen Gao; Juan Wang
Journal:  J Contemp Brachytherapy       Date:  2020-12-16

7.  Clinical outcomes of surgical resection for recurrent lesion after curative esophagectomy for esophageal squamous cell carcinoma: a nationwide, large-scale retrospective study.

Authors:  Kensuke Kudou; Hiroshi Saeki; Yuichiro Nakashima; Yasue Kimura; Eiji Oki; Masaki Mori; Mototsugu Shimokawa; Yoshihiro Kakeji; Yasushi Toh; Yuichiro Doki; Hisahiro Matsubara
Journal:  Esophagus       Date:  2021-09-12       Impact factor: 4.230

8.  The impact of lymphadenectomy on lymph node recurrence after performing various treatments for esophageal squamous cell carcinoma.

Authors:  Takashi Shigeno; Akihiro Hoshino; Shiho Matsunaga; Rumi Shimano; Naoya Ishibashi; Hajime Shinohara; Hiroyuki Shiobara; Chiharu Tomii; Katsumasa Saito; Naoto Fujiwara; Yuya Sato; Kenro Kawada; Masanori Tokunaga; Yusuke Kinugasa
Journal:  BMC Surg       Date:  2022-05-11       Impact factor: 2.102

9.  Clinical analyses on salvage lymphadenectomy through cervical incision for patients with cervical and cervicothoracic recurrences after esophagectomy.

Authors:  Dong Lin; Shujun Jiang; Longfei Ma; Hong Hu; Ting Ye; Longlong Shao; Zuodong Song; Jiaqing Xiang
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

10.  Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.

Authors:  Xiaoli Zhang; Minghuan Li; Xue Meng; Li Kong; Yan Zhang; Guangsheng Wei; Xiqin Zhang; Fang Shi; Man Hu; Guoli Zhang; Jinming Yu
Journal:  Radiat Oncol       Date:  2014-02-26       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.